DK1185520T3 - Fremgangsmåde til fremstilling af thiazolidin - Google Patents

Fremgangsmåde til fremstilling af thiazolidin

Info

Publication number
DK1185520T3
DK1185520T3 DK00925194T DK00925194T DK1185520T3 DK 1185520 T3 DK1185520 T3 DK 1185520T3 DK 00925194 T DK00925194 T DK 00925194T DK 00925194 T DK00925194 T DK 00925194T DK 1185520 T3 DK1185520 T3 DK 1185520T3
Authority
DK
Denmark
Prior art keywords
salts
thiazolidine
preparation
formula
relates
Prior art date
Application number
DK00925194T
Other languages
English (en)
Inventor
Hans-Ulrich Demuth
Susanne Kruber
Original Assignee
Probiodrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiodrug Ag filed Critical Probiodrug Ag
Application granted granted Critical
Publication of DK1185520T3 publication Critical patent/DK1185520T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00925194T 1999-06-10 2000-04-11 Fremgangsmåde til fremstilling af thiazolidin DK1185520T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19926233A DE19926233C1 (de) 1999-06-10 1999-06-10 Verfahren zur Herstellung von Thiazolidin
PCT/EP2000/003213 WO2000076986A1 (de) 1999-06-10 2000-04-11 Verfahren zur herstellung von thiazolidin

Publications (1)

Publication Number Publication Date
DK1185520T3 true DK1185520T3 (da) 2004-06-28

Family

ID=7910641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925194T DK1185520T3 (da) 1999-06-10 2000-04-11 Fremgangsmåde til fremstilling af thiazolidin

Country Status (18)

Country Link
US (1) US6559314B2 (da)
EP (1) EP1185520B1 (da)
JP (1) JP3803292B2 (da)
KR (1) KR100467898B1 (da)
CN (1) CN1169799C (da)
AT (1) ATE261946T1 (da)
AU (1) AU758605B2 (da)
BR (1) BR0011445A (da)
CA (1) CA2373834C (da)
DE (2) DE19926233C1 (da)
DK (1) DK1185520T3 (da)
ES (1) ES2215045T3 (da)
HK (1) HK1042483B (da)
MX (1) MXPA01012237A (da)
NZ (1) NZ515561A (da)
PT (1) PT1185520E (da)
RU (1) RU2218336C2 (da)
WO (1) WO2000076986A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE357509T1 (de) * 1997-09-29 2007-04-15 Point Therapeutics Inc Stimulierung von hämatopoietischen zellen im vitro
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
CN1894234A (zh) 2003-03-25 2007-01-10 武田药品工业株式会社 二肽基肽酶抑制剂
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
KR20060041309A (ko) * 2003-08-13 2006-05-11 다케다 야쿠힌 고교 가부시키가이샤 ４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2007505121A (ja) 2003-09-08 2007-03-08 武田薬品工業株式会社 ジペプチジルぺプチダーゼ阻害剤
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
AU2004318013B8 (en) 2004-03-15 2011-10-06 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2005118555A1 (en) * 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
ATE553077T1 (de) * 2004-07-23 2012-04-15 Nuada Llc Peptidaseinhibitoren
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
EP1828192B1 (en) 2004-12-21 2014-12-03 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2007033265A1 (en) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetis
HRP20140091T4 (hr) * 2005-09-14 2021-12-24 Takeda Pharmaceutical Company Limited Davanje inhibitora dipeptidil peptidaze
CA2622472C (en) 2005-09-14 2013-11-19 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
US8222411B2 (en) 2005-09-16 2012-07-17 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7833260B2 (en) * 2006-07-20 2010-11-16 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
KR20090088854A (ko) * 2006-09-13 2009-08-20 다케다 야쿠힌 고교 가부시키가이샤 2-6-(3-아미노-피페리딘-엘-일)-3-메틸-2,4-디옥소-3,4-디하이드로-2h-피리미딘-1-일메틸-4-플루오로-벤조니트릴의 용도
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
CN104910128A (zh) * 2015-06-02 2015-09-16 安徽兴东化工有限公司 一种2,2-二甲基四氢噻唑的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2961377A (en) 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3594377A (en) * 1967-11-07 1971-07-20 Uniroyal Inc Condensation products of n - (3 -thiazolidinylmethyl) - nitrogen base compounds
DE2009743A1 (de) 1970-03-03 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Substituierte Biguanide mit antihyperglykämischer Wirkung
US3960949A (en) 1971-04-02 1976-06-01 Schering Aktiengesellschaft 1,2-Biguanides
CH590857A5 (en) * 1973-05-30 1977-08-31 Givaudan & Cie Sa Substd. thiazolidine odourants flavourants - having a wide aroma spectrum and usable in small concns.
CH602612A5 (da) 1974-10-11 1978-07-31 Hoffmann La Roche
ATE15668T1 (de) * 1980-12-12 1985-10-15 Fine Organics Ltd Verfahren zur herstellung von thiazolidinderivaten.
US4935493A (en) 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
JPH01272570A (ja) * 1988-04-26 1989-10-31 Nippon Shokubai Kagaku Kogyo Co Ltd ４−メチル−５−［（２−アミノエチル）−チオメチル］−イミダゾールの製法
US5433955A (en) 1989-01-23 1995-07-18 Akzo N.V. Site specific in vivo activation of therapeutic drugs
JPH04334357A (ja) 1991-05-02 1992-11-20 Fujirebio Inc 酵素阻害作用を有するアシル誘導体
JPH07504158A (ja) 1991-10-22 1995-05-11 ニュー　イングランド　メディカル　センター　ホスピタルズ　インク ジペプチジル−アミノペプチダーゼｉｖ型のインヒビタ
IL106998A0 (en) 1992-09-17 1993-12-28 Univ Florida Brain-enhanced delivery of neuroactive peptides by sequential metabolism
FR2696740B1 (fr) 1992-10-13 1994-12-30 Dospharma Sa Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
WO1995011689A1 (en) 1993-10-29 1995-05-04 Trustees Of Tufts College Use of inhibitors of dipeptidyl-aminopeptidase to block entry of hiv into cells
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
US5543396A (en) 1994-04-28 1996-08-06 Georgia Tech Research Corp. Proline phosphonate derivatives
DE4427569A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Verfahren zur Herstellung von Cyanimino-1,3-thiazolidin
US5512549A (en) 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
US5614379A (en) 1995-04-26 1997-03-25 Eli Lilly And Company Process for preparing anti-obesity protein
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
AU3224997A (en) 1996-05-29 1998-01-05 Prototek, Inc Prodrugs of thalidomide and methods for using same as modulators of t-cell function
US6006753A (en) 1996-08-30 1999-12-28 Eli Lilly And Company Use of GLP-1 or analogs to abolish catabolic changes after surgery
AR016751A1 (es) 1996-11-22 2001-08-01 Athena Neurosciences Inc Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo
EP1092046A4 (en) 1998-07-02 2003-02-19 Invitro Diagnostics Inc METHODS, COMPOSITIONS AND DEVICE FOR MANUFACTURING NUCLEIC ACIDS HAVING SELECTIVE AFFINITY FOR A TARGET MOLECULE
WO2000053171A1 (en) 1999-03-05 2000-09-14 Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
WO2001062266A2 (en) 2000-02-25 2001-08-30 Novo Nordisk A/S Use of dpp-iv inhibitors for the treatment of diabetes

Also Published As

Publication number Publication date
ES2215045T3 (es) 2004-10-01
JP3803292B2 (ja) 2006-08-02
PT1185520E (pt) 2004-08-31
AU4399600A (en) 2001-01-02
KR20020022688A (ko) 2002-03-27
US20020082427A1 (en) 2002-06-27
CN1169799C (zh) 2004-10-06
JP2003502319A (ja) 2003-01-21
DE19926233C1 (de) 2000-10-19
KR100467898B1 (ko) 2005-02-21
HK1042483A1 (en) 2002-08-16
AU758605B2 (en) 2003-03-27
EP1185520A1 (de) 2002-03-13
BR0011445A (pt) 2002-03-19
ATE261946T1 (de) 2004-04-15
EP1185520B1 (de) 2004-03-17
DE50005699D1 (de) 2004-04-22
HK1042483B (zh) 2004-09-10
NZ515561A (en) 2003-06-30
MXPA01012237A (es) 2002-08-12
US6559314B2 (en) 2003-05-06
CA2373834A1 (en) 2000-12-21
WO2000076986A1 (de) 2000-12-21
CA2373834C (en) 2005-11-08
RU2218336C2 (ru) 2003-12-10
CN1355795A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
DK1185520T3 (da) Fremgangsmåde til fremstilling af thiazolidin
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
MXPA03005429A (es) Procedimiento para preparacion de imidazotriazinonas sustituidas con sulfonamida.
ATE261953T1 (de) Verfahren zur herstellung von citalopram
DE60311456D1 (de) Verfahren zur herstellung von eisenhydroxypyronverbindungen
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE293632T1 (de) Verfahren zur herstellung von alkylverbrückten ligandsystemen und übergangsmetallverbindungen
DE69931493D1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
ATE370940T1 (de) Verfahren zur herstellung von (s)- glyceraldehydacetonid
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
ATE172734T1 (de) Verfahren zur herstellung von ceftriaxon
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE390400T1 (de) Verfahren zur herstellung von alpha'-chlorketonen
DE69821763D1 (de) Verfahren zur herstellung von 2-alkylthio-substituierten benzoesäurederivaten
ATE251616T1 (de) Verfahren zur herstellung von 5- hydroxymethylthiazole
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester
ATE250581T1 (de) Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin
DE69612237D1 (de) Verfahren zur Herstellung von alpha-Methyl-2-thiophenessigsäure-Derivaten
ATE236135T1 (de) Verfahren zur herstellung von 4,6- dichlorpyrimidin
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE253553T1 (de) Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten
DE60225338D1 (de) Verfahren zur herstellung von derivaten von 3,3-dimethyl-2-formylcyclopropanekarbonsäure